Management of the Cancer Drugs Fund is a matter for NHS England. Ministers have not had any discussions with NHS England on the management of the fund but departmental officials have regular discussions with NHS England about the Cancer Drugs Fund, including the financial position. NHS England collects expenditure information for the Cancer Drugs Fund on a monthly basis from its regional area teams and we are advised that forecasting arrangements are also in place. NHS England is considering future publication arrangements for expenditure information. The Cancer Drugs Fund is clinically led. NHS England has taken a number of steps to help clinicians make best use of the fund, including: publishing national Standard Operating Procedures for the Fund, which explain how drug/indication combinations are assessed for inclusion in the fund, taking into account clinical and cost-effectiveness; developing a National Cancer Drugs Fund list of drugs and indications that will be routinely funded; and developing arrangements for dealing with individual funding requests for drugs not included on the national list.